SONN icon

Sonnet BioTherapeutics

15 hedge funds and large institutions have $1.09M invested in Sonnet BioTherapeutics in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.

Holders
15
Holders Change
-6
Holders Change %
-28.57%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TDC
1
Thompson Davis & Co
Virginia
$314K 387,197 +5,554 +1%
Bank of America
2
Bank of America
North Carolina
$205K 252,828
Vanguard Group
3
Vanguard Group
Pennsylvania
$176K 217,873
IC
4
Intersect Capital
California
$100K 123,783
BIT
5
BlackRock Institutional Trust
California
$82K 101,212
EVC
6
Eidelman Virant Capital
Missouri
$62.4K 77,000 -8,000 -9%
GHAM
7
Gilman Hill Asset Management
Connecticut
$49K 59,890
CDH
8
Charles D. Hyman
$36K 44,444
SI
9
SII Investments
Wisconsin
$24K 30,000 +30,000 New
CL
10
CSS LLC
Illinois
$18K 22,728
Northern Trust
11
Northern Trust
Illinois
$14K 17,646
BFA
12
BlackRock Fund Advisors
California
$4K 5,328 +1,078 +25%
BIM
13
BlackRock Investment Management
Delaware
$3K 3,485
Morgan Stanley
14
Morgan Stanley
New York
$1K 1,464 -86,616 -98%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$74 92,136
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
-23,952 Closed
Goldman Sachs
17
Goldman Sachs
New York
-18,943 Closed
TSS
18
Two Sigma Securities
New York
-16,121 Closed
VKH
19
Virtu KCG Holdings
New York
-12,058 Closed
CG
20
Cutler Group
California
-3,252 Closed
IA
21
IFP Advisors
Florida
-2,000 Closed
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
-16 Closed